These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7860227)

  • 1. Weekly gemcitabine in advanced or metastatic solid tumors. A clinical phase I study.
    Pollera CF; Ceribelli A; Crecco M; Calabresi F
    Invest New Drugs; 1994; 12(2):111-9. PubMed ID: 7860227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged infusion gemcitabine: a clinical phase I study at low- (300 mg/m2) and high-dose (875 mg/m2) levels.
    Pollera CF; Ceribelli A; Crecco M; Oliva C; Calabresi F
    Invest New Drugs; 1997; 15(2):115-21. PubMed ID: 9220290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study.
    Pollera CF; Ceribelli A; Crecco M; Calabresi F
    Ann Oncol; 1994 Feb; 5(2):182-4. PubMed ID: 8186164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
    Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
    Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors.
    Touroutoglou N; Gravel D; Raber MN; Plunkett W; Abbruzzese JL
    Ann Oncol; 1998 Sep; 9(9):1003-8. PubMed ID: 9818075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors.
    Brand R; Capadano M; Tempero M
    Invest New Drugs; 1997; 15(4):331-41. PubMed ID: 9547676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
    Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
    Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.
    Fossella FV; Lippman SM; Shin DM; Tarassoff P; Calayag-Jung M; Perez-Soler R; Lee JS; Murphy WK; Glisson B; Rivera E; Hong WK
    J Clin Oncol; 1997 Jan; 15(1):310-6. PubMed ID: 8996158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study.
    Lüftner D; Flath B; Akrivakis C; Mergenthaler HG; Ohnmacht U; Arning M; Possinger K
    Invest New Drugs; 1998; 16(2):141-6. PubMed ID: 9848577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
    Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
    Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors.
    Amarantidis K; Houhouli K; Papatheodorou K; Miloussis A; Matthaios D; Chatzaki E; Lyrantzopoulos N; Tsaroucha A; Tentes A; Kakolyris S
    Oncol Res; 2006; 16(6):281-7. PubMed ID: 17476973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report.
    Shepherd FA; Burkes R; Cormier Y; Crump M; Feld R; Strack T
    Lung Cancer; 1996 Feb; 14(1):135-44. PubMed ID: 8696717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors.
    Yuan Y; Cohen DJ; Love E; Yaw M; Levinson B; Nicol SJ; Hochster HS
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):371-8. PubMed ID: 20978761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of gemcitabine and infusional 5-fluorouracil (5-FU) in patients with refractory solid tumors: Louisiana Oncology Associates protocol no. 1 (LOA-1).
    Rinaldi DA; Lormand NA; Brierre JE; Cole JL; Stagg MP; Fontenot MF; Buller EJ; Rainey JM
    Am J Clin Oncol; 2000 Feb; 23(1):78-82. PubMed ID: 10683085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.
    Anderson H; Lund B; Bach F; Thatcher N; Walling J; Hansen HH
    J Clin Oncol; 1994 Sep; 12(9):1821-6. PubMed ID: 8083706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
    Hidalgo M; Castellano D; Paz-Ares L; Gravalos C; Diaz-Puente M; Hitt R; Alonso S; Cortes-Funes H
    J Clin Oncol; 1999 Feb; 17(2):585-92. PubMed ID: 10080603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.
    Delord JP; Raymond E; Chaouche M; Ruffie P; Ducreux M; Faivre S; Boige V; Le Chevalier T; Rixe O; Baudin E; Pautier P; Rodier JM; Chouaki N; Escudier B; Kayitalire L; Armand JP
    Ann Oncol; 2000 Jan; 11(1):73-9. PubMed ID: 10690391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study.
    Steward WP; Dunlop DJ; Cameron C; Talbot DC; Kleisbauer JP; Thomas P; Guerin JC; Perol M; Sanson C; Dabouis G
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():33-7. PubMed ID: 8718423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of gemcitabine in advanced colorectal adenocarcinoma.
    Moore DF; Pazdur R; Daugherty K; Tarassoff P; Abbruzzese JL
    Invest New Drugs; 1992 Nov; 10(4):323-5. PubMed ID: 1487408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.
    Tassinari D; Drudi G; Panzini I; Pasini G; Arcangeli V; Fochessati F; Gianni L; Mianulli AM; Oliverio G; Pasquini E; Sartori S; Ravaioli A
    Int J Clin Oncol; 2001 Dec; 6(6):279-83. PubMed ID: 11828946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.